[Combination of docetaxel and cisplatin in the treatment of advanced non-small cell lung cancer].
Cited by 0
Related Papers
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
|JAMA Oncology|2019|694
Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I
|Nature Cell Biology|1999|491
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417